NECLIFENSENECTAR LIFESCIENCES LTD.· PharmaceuticalsLowNeutral
Announced Fri, 18 Sept · 12:25 IST

Proceedings of 31st AGM held on September 18, 2026

Board & Shareholder Meetings View source PDFExplain this filing

NECLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-1.3%1-day move
₹11.00
prior close
₹10.95
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.1-1.3
Up moveDown movePending
AI summary

31st AGM held on September 18, 2026 via video conferencing from 11:00 to 11:25 AM IST with all 6 directors present. Statutory and Secretarial Auditors gave unqualified opinions for FY 2025-26. Five resolutions were transacted: adoption of standalone and consolidated financial statements for FY ended March 31, 2026; re-appointment of CMD Sanjiv Goyal by rotation; re-appointment of two Independent Directors for a second five year term; and appointment of Dr. Gunmala Suri as Non-Executive Non-Independent Director. Voting results to be filed within 2 working days.

Likely market impact

Routine AGM with clean audit reports and standard re-appointments; voting results awaited to confirm shareholder approval.